The short answer
Fish oil is not automatically incompatible with dabigatran etexilate. A large surgical trial did not find increased bleeding with mixed EPA/DHA fish oil, but it did not establish safety for every product combined long term with dabigatran. Review the formulation and dose; an evidence-based spacing interval is not established.
What this answer covers
Oral fish oil supplements containing EPA/DHA with adult oral dabigatran etexilate. Pure EPA prescription products, other omega-3 sources and combination products require separate assessment.
- Supplement or preparation
- Fish Oil
- Medication ingredient
- dabigatran etexilate
Does fish oil always increase bleeding?
In the OPERA trial, 1,516 cardiac-surgery patients received mixed EPA/DHA fish oil or placebo. Major perioperative bleeding was not increased with fish oil: the odds ratio was 0.81 with a 95% confidence interval of 0.53 to 1.24. This challenges a blanket statement that fish oil invariably causes excess bleeding.
How close is that evidence to my situation?
The regimen used a short preoperative loading course followed by postoperative fish oil. It was not designed to test chronic fish oil plus dabigatran etexilate as an isolated pair. Dabigatran already increases bleeding risk. Kidney function matters because impaired clearance can increase exposure to active dabigatran. A neutral average result in one surgical population cannot clear every anticoagulated patient or higher-dose formulation.
What should I check on the bottle?
The total fish-oil weight is different from the amount of EPA and DHA. Record both, along with serving size and other ingredients. Prescription pure EPA is not the same intervention as the mixed EPA/DHA trial. Product choice, reason for treatment and the rest of the medication list belong in the assessment.
Should the doses be separated?
No study in the inspected evidence establishes a protective hourly gap or a universal need to avoid fish oil with dabigatran etexilate. Discuss the supplement before starting or changing it, especially with additional aspirin or a prior bleeding problem. Continue prescribed anticoagulation and seek prompt advice for unusual bleeding instead of independently changing its schedule.
Evidence and practical considerations
Timing & monitoring
Fish oil is not automatically incompatible with dabigatran etexilate. A large surgical trial did not find increased bleeding with mixed EPA/DHA fish oil, but it did not establish safety for every product combined long term with dabigatran. Review the formulation and dose; an evidence-based spacing interval is not established.
- Exact scope
- Oral fish oil supplements containing EPA/DHA with adult oral dabigatran etexilate. Pure EPA prescription products, other omega-3 sources and combination products require separate assessment. with adult oral dabigatran etexilate mesylate capsules; active dabigatran produced after absorption
- Medication form and route
- adult oral dabigatran etexilate mesylate capsules; active dabigatran produced after absorption
- Timing or duration
- Concurrent oral use. Source-specific durations are recorded in the evidence entries; no unstudied duration threshold or separation schedule is inferred.
What remains uncertain
- Neutral randomized bleeding data are indirect for the exact anticoagulant pair and do not cover all omega-3 formulations or chronic high-dose co-use. No tested timing solution.
Factors that may matter: Exact supplement preparation, dose and additional ingredients; Kidney function, age, bleeding history and other antiplatelet or anticoagulant medicines; Current medication formulation and recent supplement start or stop.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients receiving oral dabigatran etexilate capsules.
P-gp induction reduces active dabigatran exposure. P-gp inhibition and impaired renal function increase exposure. Capsules must be swallowed intact. RE-LY trough concentrations were not appreciably changed by concomitant PPIs or H2 blockers.
How this applies: Establishes the exact medicine’s mechanism, baseline bleeding precautions and formulation/transport limitations; it does not establish this supplement-specific interaction. Exact scope: Oral fish oil supplements containing EPA/DHA with adult oral dabigatran etexilate. Pure EPA prescription products, other omega-3 sources and combination products require separate assessment.
Named medicine dose adjustments cannot be extrapolated to untested herbs. Label silence about a supplement does not prove compatibility. Capsule results must not be generalized to every formulation.
Source 2: original randomized human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 1,516 patients undergoing cardiac surgery.
No increase in major perioperative bleeding: odds ratio 0.81, 95% CI 0.53-1.24. Transfused units were lower.
How this applies: Original mixed EPA/DHA bleeding trial counters an assumed universal bleeding effect. It did not isolate chronic dabigatran etexilate plus fish oil or all omega-3 products. Exact scope: Oral fish oil supplements containing EPA/DHA with adult oral dabigatran etexilate. Pure EPA prescription products, other omega-3 sources and combination products require separate assessment.
Not a trial of chronic fish oil plus a specific direct oral anticoagulant; short surgical setting and mixed EPA/DHA, not all omega-3 formulations.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current labels and targeted original sources assessed; all current available claims adjudicated and consumer article prepared. Uncertainty and indirect evidence retained. Clinical sign-off not recorded. | |
| Research summary published |
Article revision: 649c525edbec3066
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.